Convulsant bicuculline modifies CNS muscarinic receptor affinity

BACKGROUND: Previous work from this laboratory has shown that the administration of the convulsant drug 3-mercaptopropionic acid (MP), a GAD inhibitor, modifies not only GABA synthesis but also binding of the antagonist [(3)H]-quinuclidinyl benzilate ([(3)H]-QNB) to central muscarinic receptors, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Schneider, Patricia G, Rodríguez de Lores Arnaiz, Georgina
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1463000/
https://www.ncbi.nlm.nih.gov/pubmed/16615872
http://dx.doi.org/10.1186/1471-2202-7-32

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1463000/
https://www.ncbi.nlm.nih.gov/pubmed/16615872
http://dx.doi.org/10.1186/1471-2202-7-32

Ejemplares similares